TotalSeq™-B1219 anti-IRF6 Antibody, IRF6, 14B2C16,BioLegend,674509

Host

Mouse

Reactivity

Human

Application

ICPG - Quality tested

Platform ID

BAB542596424

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B1219 anti-IRF6 Antibody, IRF6, 14B2C16
Cat. No.674509
HostMouse
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationICPG - Quality tested
ClonalityMonoclonal
Clone Number14B2C16
Concentration0.5 mg/mL
TargetIRF6
ImmunogenPartial human IRF6 recombinant protein (92-223 a.a.) expressed inE. coli.
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

IRF6 is a member of the IRF family of transcription factors, which are based on the presence of the conserved IRF tryptophan pentad repeat DNA-binding domain. Unlike other IRF transcription factors, IRF6 is not involved in the expression of interferon genes and doesn’t seem to be involved in innate immunity. Data suggests that IRF6 is necessary for appropriate epidermal differentiation and development. Mutations of IRF6 are associated with human craniofacial developmental defects such as cleft lip, palate, tooth agenesis, Van der Woude syndrome, and popliteal pterygium syndrome. IRF6-deficient mice display severe morphological defects in skin and limbs, and result in perinatal lethality as well.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.